Barclays
NYMX

Barclays’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Barclays’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,046
Closed -$10K – 4877
2021
Q3 		$10K Sell
5,046
-3,861
-43% -$6.84K ﹤0.01% 4525
2021
Q2 		$14K Sell
8,907
-26,451
-75% -$49K ﹤0.01% 4572
2021
Q1 		$79K Buy
35,358
+21,706
+159% +$57.2K ﹤0.01% 4085
2020
Q4 		$34K Sell
13,652
-5,278
-28% -$11.7K ﹤0.01% 4560
2020
Q3 		$47K Sell
18,930
-2,639
-12% -$7.68K ﹤0.01% 4643
2020
Q2 		$77K Buy
+21,569
New +$68.2K ﹤0.01% 4693
2019
Q3 		– Sell
-1
Closed – – 7267
2019
Q2 		$0 Sell
1
-9,260
-100% -$16.2K ﹤0.01% 7398
2019
Q1 		$18K Buy
9,261
+8,762
+1,756% +$18.6K ﹤0.01% 6396
2018
Q4 		$0 Sell
499
-11,801
-96% -$21.6K ﹤0.01% 7477
2018
Q3 		$30K Buy
12,300
+9,929
+419% +$29.3K ﹤0.01% 6321
2018
Q2 		$8K Sell
2,371
-4,508
-66% -$17.3K ﹤0.01% 6622
2018
Q1 		$28K Buy
6,879
+1,332
+24% +$4.62K ﹤0.01% 6285
2017
Q4 		$19K Buy
5,547
+4,842
+687% +$17.7K ﹤0.01% 6318
2017
Q3 		$3K Sell
705
-3,517
-83% -$13.3K ﹤0.01% 6618
2017
Q2 		$18K Buy
+4,222
New +$17.3K ﹤0.01% 5849

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

Barclays's NYMX Position: Q4 2021 in Review

Barclays sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2021, closing a stake of 5,046 shares — an estimated $10K sold.

Barclays first reported a position in NYMX in Q2 2017 and held it in 15 quarters. The position peaked at $79K in Q1 2021. 43 funds tracked by Wall St. Rank hold NYMX as of Q4 2021.

  • Barclays reported no remaining Nymox Pharmaceutical Corp position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 5,046 Nymox Pharmaceutical Corp shares in Q4 2021, an estimated $10K.
  • Barclays first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 15 quarters.
  • Barclays's Nymox Pharmaceutical Corp position peaked at $79K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.